Posted inGlobal News Osimertinib plus chemotherapy improves PFS in advanced EGFR+ NSCLC The combination of osimertinib (Tagrisso) and platinum-based chemotherapy led to a statistically significant and clinically meaningful improvement in… Posted by finxhost May 17, 2023
